Encompass Health Corporation (EHC) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
EHC Revenue Growth
Revenue Breakdown (FY 2025)
EHC's revenue distribution by segment and geography for fiscal year 2025
By Product/Segment
EHC Revenue Analysis (2014–2025)
As of May 7, 2026, Encompass Health Corporation (EHC) generated trailing twelve-month (TTM) revenue of $6.07 billion, reflecting solid growth of +9.0% year-over-year. The most recent quarter (Q1 2026) recorded $1.59 billion in revenue, up 2.7% sequentially.
Looking at the longer-term picture, EHC's 5-year compound annual growth rate (CAGR) stands at +10.7%, indicating consistent double-digit revenue growth. The company achieved its highest annual revenue of $5.94 billion in 2025, representing a new all-time high.
Revenue diversification analysis shows EHC's business is primarily driven by Inpatient (97%), and Other (3%). With over half of revenue concentrated in Inpatient, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including USPH (+4.0% YoY), SEM (+29.2% YoY), and ENSG (+19.2% YoY), EHC has underperformed the peer group in terms of revenue growth. Compare EHC vs USPH →
EHC Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| EHCCurrent | $6.1B | +9.0% | +10.7% | 17.7% | |
 USPH | $781M | +4.0% | +13.0% | 10.3% | |
 SEM | $5.5B | +29.2% | -0.3% | 6.1% | |
 ENSG | $5.1B | +19.2% | +16.1% | 8.6% | |
 ACHC | $3.3B | +6.8% | +9.7% | 11.7% | |
 UHS | $17.4B | +10.4% | +8.5% | 11.5% |
EHC Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $5.94B | +10.5% | $5.68B | 95.7% | $1.05B | 17.7% |
| 2024 | $5.37B | +11.9% | $2.23B | 41.6% | $864.5M | 16.1% |
| 2023 | $4.80B | +10.4% | $1.98B | 41.3% | $1.72B | 35.9% |
| 2022 | $4.35B | +8.3% | $1.75B | 40.3% | $630.2M | 14.5% |
| 2021 | $4.01B | +12.6% | $1.70B | 42.4% | $659.4M | 16.4% |
| 2020 | $3.57B | -22.6% | $3.40B | 95.2% | $0 | - |
| 2019 | $4.61B | +7.7% | $4.44B | 96.4% | $692.5M | 15.0% |
| 2018 | $4.28B | +9.3% | $4.12B | 96.3% | $681.6M | 15.9% |
| 2017 | $3.91B | +7.4% | $3.76B | 96.2% | $649.4M | 16.6% |
| 2016 | $3.64B | +16.9% | $3.50B | 96.2% | $648.8M | 17.8% |
Full EHC Stock Analysis
Analyst consensus, bull case, AI-generated risk factors, and peer comparison — all in one place.
See EHC's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs EHC Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare EHC vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonEHC — Frequently Asked Questions
Quick answers to the most common questions about buying EHC stock.
Is EHC's revenue growth accelerating or slowing?
EHC maintains +9.0% revenue growth, in line with its 5-year CAGR of +10.7%. TTM revenue stands at $6.1B. Growth rate remains consistent with historical average.
What is EHC's long-term revenue growth rate?
Encompass Health Corporation's 5-year revenue CAGR of +10.7% reflects the sustained expansion pattern. Current YoY growth of +9.0% is near this long-term average.
How is EHC's revenue distributed by segment?
EHC reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.